Expert Advice 8 May 2019
Why It’s Important to “Think Big” When Raising Money for Your Company
There are not many people who can say they led one of Europe’s largest biotechs and launched the first approved…
Hookipa
- Latest Posts
News and Trends 18 Apr 2019
Hookipa’s €75M IPO to Fund Vaccines for Viral Infection and Cancer
The Austrian biotech Hookipa expects to raise €75M ($84M) in an IPO on the Nasdaq stock exchange to fund the…
News and Trends 28 Feb 2019
Austrian Biotech Raises €33.2M to Fund Cancer Vaccines
A Series D round of €33.2M ($37.4M) is to help the biotech Hookipa advance the clinical development of therapeutic vaccines…
News and Trends 3 Jan 2019
Austrian Biopharma Reaches First HIV Vaccine Milestone
Hookipa Pharma has reached its first milestone in a partnership deal with US-based CAR T pioneers Gilead Sciences to develop…
ADVERTISEMENT
Interview 7 Feb 2018
Hookipa CEO “Sleeps Quite Well at Night” with €50M Cash Pile and Cancer Vaccine Progress
Did you miss us in Vienna? Here's the first of our two interviews from the Refresh meetup last month: Jörn…
News and Trends 14 Dec 2017
Someone’s Popular! Gilead is Just One Big Name Investing in this Vaccine Biotech
Gilead has joined a growing list of powerful investors that want to help Hookipa Biotech develop its vaccine technology by…
In Depth 20 Jun 2017
Boosting the Immune System with Vaccines to Fight Cancer: A Review
Immunotherapies have been taking the biotech world by storm. Among these are cancer vaccines, which are directed at solid tumors…
News and Trends 4 May 2017
Solid First-in-Human Results from Vaccine against Birth Defects
Hookipa has presented positive data from its first Phase I trial testing its vaccine technology against human cytomegalovirus (hCMV) infections.…
Best in Biotech 3 Jan 2017
10 Hot European Biotechs to Observe in 2017 🚀
New year, new list: here are the 10 hottest Biotech companies I will watch closely in 2017 and why. This…
News and Trends 18 Oct 2016
€4M Grant for a Cancer Vaccine that could Bench its Competitors
Hookipa just secured a huge grant from the Austrian government. The plan is to develop the strongest HPV vaccine ever and…
ADVERTISEMENT
News and Trends 12 Sep 2016
Grüßgott, get to Meet 9 exciting Biotechs from Vienna
Classical music, the Danube, Schnitzel, and apple strüdel - a typical combination of Vienna. The city has also been at…
News and Trends 21 Jul 2016
Former uniQure and Evotec CEO pushes new viral candidate into Clinical Trials
Hookipa is starting its first clinical trial for a vaccine against human cytomegalovirus. This is the leading candidate of its…